The Janssen experimental injection is a recombinant vector that uses a human adenovirus to express the SARS-CoV-2 spike protein. SARS-CoV-2 is the virus that causes COVID-19. Adenoviruses are a group of viruses that cause infections in the respiratory and gastrointestinal tracts.
J&J’s vaccine uses a modified adenovirus instead of messenger RNA to trigger an immune response to combat the novel coronavirus.
This vaccine like the mRNA genetic modification experimental procedures masquerading as vaccines from Moderna and Pfizer, also received emergency approval, thereby bypassing the usual trials on laboratory animals. If you take this injection, you are taking the place of these animals in this experiment.
13.05.2021 USA – 57-Year-Old Syracuse Man Mocks “Anti-vaxxers,” DEAD Seven Days After Johnson & Johnson Shot.
Mr. Ronald Babb, Sr. received the experimental Johnson & Johnson viral vector shot on April 12, according to his Facebook page. Mr. Babb posted he and his wife’s “vaccine cards” on Facebook with a caption saying they are now waiting to “turn into robots.”
06.05.2021 USA – 35-Year-Old Woman Dies of Brain Hemorrhage 11 Days After Receiving J&J Vaccine.
She received the J&J shot on April 8, five days before the CDC paused the vaccine to investigate reports of potentially dangerous blood clots in women who received the shot.
Symptoms of the rare blood clots typically develop six to 15 days after getting the shot.
27.04.2021 – J&J COVID-19 untested injection will now feature a safety label warning that it may cause blood clots. The US CDC and FDA have lifted their pause on use of Johnson & Johnson’s coronavirus injection with a condition that it will now include a safety label warning that its experimental genetic modification procedure comes with blood clot risks.
22. 03.2021 People Now Dying. Reports are now surfacing of people dying following the recently authorized Johnson and Johnson experimental COVID shots in the United States Following the Experimental Johnson and Johnson COVID Injections. Read More HERE >>